AzTrials
AzTrials

Procedural PainNCT07763132

Comparison of Virtual Reality, EMLA Cream, and Standard Care for Pain During Blood Draws in Children

A study testing Virtual Reality Distraction and Lidocaine-Prilocaine Cream in people with Procedural Pain, run by Marie Lulková at 1 site in Czechia.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized controlled trial evaluates methods to reduce pain during venipuncture in children aged 3 to 15 years. The study compares three approaches: virtual reality distraction using a VR headset, topical anesthesia with EMLA cream, and standard care without an additional pain-reducing intervention. Read more about this study

Who is it for?
Ages 3 to 15 years
Conditions the study is for
Procedural Pain
What is being tested?
Virtual Reality Distraction and Lidocaine-Prilocaine Cream
Could I receive a placebo?
No, everyone receives an active treatment
How many people
450 participants
Where
1 siteCzechia
Study dates
1 Sep 2024to Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 15 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children aged 3 to 15 years.
  • Clinical indication for venipuncture.
  • Written informed consent provided by a parent or legal guardian and verbal or written assent from the child, as appropriate for age and cognitive ability.

Who cannot join

  • Known hypersensitivity to local anesthetics.
  • Diagnosed mental disorder.
  • Current treatment with analgesic or anxiolytic medications.
  • Venipuncture not successful on the first attempt.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Marie Lulková, Mgr. contact

+420733756630

marie.lulkova@kzcr.eu

Czechia1 site, 1 recruiting
  • Krajska zdravotni, a.s. - Masarykova nemocnice v Usti nad Labem

    Ústí nad Labem, Ústí nad Labem Region, 40011

    Marie Lulková, Mgr., +420733756630, marie.lulkova@kzcr.eu

    Recruiting

Other trials in Czechia

About this study

Official title: Comparison of the Efficacy of Virtual Reality and Topical Anesthetic During Venipuncture in Children: a Randomized Controlled Trial

This randomized controlled trial evaluates methods to reduce pain during venipuncture in children aged 3 to 15 years. The study compares three approaches: virtual reality distraction using a VR headset, topical anesthesia with EMLA cream, and standard care without an additional pain-reducing intervention. The main question is whether virtual reality reduces pain during venipuncture more effectively than EMLA cream or standard care. Pain is assessed immediately after venipuncture using the Wong-Baker Faces Pain Rating Scale (0-10). The planned study sample includes 450 children.

Conditions
Procedural Pain
Being tested
Virtual Reality Distraction, Lidocaine-Prilocaine Cream
Keywords
Venipuncture, Virtual Reality, EMLA Cream, Topical Anesthesia, Pediatric Pain, Children, Distraction
Medical subject headings
Pain, Procedural

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality DistractionBehavioural

    Virtual reality distraction is provided during venipuncture using a Meta Quest 3 headset. All participants assigned to this intervention view the same 360° wildlife video. Children can change the direction of view by moving their head but cannot control the content or sequence of the video. The headset is used throughout the venipuncture procedure.

  • Lidocaine-Prilocaine CreamDrug

    Topical EMLA cream containing lidocaine and prilocaine is applied to the planned venipuncture site, covered with an occlusive dressing, and left in place for at least 60 minutes before venipuncture.

Study groups in NCT07763132
Study groupRoleWhat they receive
Virtual RealityExperimentalChildren assigned to this arm receive virtual reality distraction during venipuncture using a Meta Quest 3 headset. The same 360° wildlife video is presented to all participants. Children can change the direction of view by moving their head but cannot control the content or sequence of the video. The headset is used throughout the venipuncture procedure.
Receives: Behavioral: Virtual Reality Distraction
EMLA CreamActive comparatorChildren assigned to this arm receive topical EMLA cream containing lidocaine and prilocaine at the planned venipuncture site. The application site is covered with an occlusive dressing, and the cream is left in place for at least 60 minutes before venipuncture.
Receives: Drug: Lidocaine-Prilocaine Cream
Standard CareNo interventionChildren assigned to this arm receive standard nursing care during venipuncture according to routine clinical practice. No additional pharmacological or non-pharmacological intervention specifically aimed at reducing procedural pain is provided.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Intensity During Venipuncture

    Pain intensity is self-reported immediately after venipuncture using the Wong-Baker Faces Pain Rating Scale (0-10), where 0 indicates no pain and 10 indicates the worst pain. Lower scores indicate lower perceived pain intensity.

    Measured: Immediately after venipuncture

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Aug 2026
  2. Study start1 Sep 2024
  3. Primary completionJun 2027 (estimated)
  4. Study completionJun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
450 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07763132
Sponsor's protocol ID
321/1
Status last verified
Aug 2026
First submitted
8 Aug 2026
Last updated
13 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality Distraction and Lidocaine-Prilocaine Cream in people with Procedural Pain, run by Marie Lulková at 1 site in Czechia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Marie Lulková, Mgr. (+420733756630, marie.lulkova@kzcr.eu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Intensity During Venipuncture (time frame: Immediately after venipuncture). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in